AW

Anna M. Wu

University of California: 17 patents #237 of 18,278Top 2%
CH City Of Hope: 9 patents #37 of 524Top 8%
Stanford University: 3 patents #828 of 5,197Top 20%
SU Stanford University: 1 patents #58 of 261Top 25%
📍 West Hollywood, CA: #30 of 1,485 inventorsTop 3%
🗺 California: #23,010 of 386,348 inventorsTop 6%
Overall (All Time): #173,983 of 4,157,543Top 5%
24
Patents All Time

Issued Patents All Time

Showing 1–24 of 24 patents

Patent #TitleCo-InventorsDate
10407503 Fully human antibodies and fragments recognizing human c-Met Keyu Li 2019-09-10
9765155 Covalent disulfide-linked diabodies and uses thereof John E. Shively, Andrew A. Raubitschek, Mark A. Sherman, Tove Olafsen 2017-09-19
9701754 Covalent disulfide-linked diabodies and uses thereof John E. Shively, Andrew A. Raubitschek, Mark A. Sherman, Tove Olafsen 2017-07-11
9624304 Antibodies which bind to epithelial membrane protein 2 (EMP2) Jonathan Braun, Lynn K. Gordon, Kaori Shimazaki Dadgostar, Madhuri Wadehra, Kathy A. Kelly 2017-04-18
9527919 High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection Robert E. Reiter, Eric J. Lepin, James D. Marks, Yu Zhou 2016-12-27
9011857 Methods of treating cancer by administering EMP2 antibodies Jonathan Braun, Lynn K. Gordon, Kaori Shimazaki, Madhuri Wadehra, Kathy A. Kelly 2015-04-21
8940298 High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection Robert E. Reiter, Eric J. Lepin, James D. Marks, Yu Zhou 2015-01-27
8940871 Engineered anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting Robert E. Reiter 2015-01-27
8785602 EMP2 antibodies and methods of use thereof for causing regression of a solid tumor or symptoms thereof Jonathan Braun, Lynn K. Gordon, Kaori Shimazaki Dadgostar, Madhuri Wadehra, Kathleen A. Kelly 2014-07-22
8779104 EMP2 antibodies and methods of use thereof causing regression of a solid tumor or symptoms thereof Jonathan Braun, Lynn K. Gordon, Kaori Shimazaki Dadgostar, Madhuri Wadehra, Kathleen A. Kelly 2014-07-15
8703920 Fully human antibodies against N-cadherin Robert E. Reiter, Eric J. Lepin 2014-04-22
8404817 Humanized anti-prostate stem cell antigen monoclonal antibody Mark A. Sherman, Robert E. Reiter 2013-03-26
8378086 Luciferases and methods for making and using the same Sanjiv S. Gambhir, Andreas M. Loening 2013-02-19
8318906 EMP2 antibodies and their therapeutic uses Jonathan Braun, Lynn K. Gordon, Kaori Shimizaki, Madhuri Wadegra-Dhawan, Kathy A. Kelly 2012-11-27
8258277 Luciferases and methods for making and using the same Sanjiv S. Gambhir, Andreas M. Loening 2012-09-04
8173791 Luciferases and methods for making and using the same Sanjiv S. Gambhir, Andreas M. Loening 2012-05-08
8088908 Humanized anti-prostate stem cell antigen monoclonal antibody Mark A. Sherman, Robert E. Reiter 2012-01-03
8043830 Biotin-ligase system for secretion of biotinylated protein Bhaswati Barat 2011-10-25
7939649 Polynucleotide encoding luciferase Sanjiv S. Gambhir, Andreas M. Loening 2011-05-10
7776330 Humanized anti-CEA T84.66 antibody and uses thereof Paul Yazaki, Mark A. Sherman, John E. Shively, Andrew A. Raubitschek 2010-08-17
7727525 Engineered anti-CD20 antibody fragments for in vivo targeting and therapeutics Tove Olafsen, Andrew A. Raubitschek 2010-06-01
7273608 Humanized anti-CEA T84.66 antibody and uses thereof Paul Yazaki, Mark A. Sherman, John E. Shively, Andrew A. Raubitschek 2007-09-25
6410319 CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies Andrew A. Raubitschek, Michael C. Jensen 2002-06-25
5837821 Antibody construct 1998-11-17